Australia's private health insurance sector delivered its clearest signal yet on the government's rebate overhaul this week, as submissions to a Senate inquiry closed with 30 of the 33 received explicitly opposing the Private Health Insurance Amendment (Modernising the Private Health Insurance Rebate) Bill 2026.
Members Health Fund Alliance, the peak body representing more than 20 not-for-profit and member-owned health funds, told the Senate Community Affairs Legislation Committee it strongly opposes the bill and called on the committee to reject it outright. The submission argues that the government's assumptions understate how older Australians will respond to higher premiums and warns that the changes will shift healthcare demand from private to public hospitals in ways the modelling has not adequately captured.
The bill would remove age-based rebate uplifts from April 1, 2027, cutting the base-tier rebate for policyholders aged 70 and over from 32.158% to 24.118% and for those aged 65 to 69 from 28.139% to 24.118% - aligning all ages to the rate currently applying to under-65 policyholders. Members Health estimates the effective premium increase for directly affected members at around 9%, with some facing increases closer to 12% on top of normal annual premium rises, and some older couples facing additional annual costs of up to $1,600. The government's own estimate puts the average impact at approximately $250 per year. The bill's stated purpose is to recoup up to $3 billion in savings to fund aged care beds and home care packages.
The clinical stakes of the debate were sharpened by a submission from the Colorectal Surgical Society of Australia and New Zealand. CSSANZ president Frank Frizelle and vice president Michael Johnston wrote that the policy would prompt some older Australians to abandon private cover in favour of public colorectal surgery, where waiting lists are already long. They noted that early detection produces cure rates of around 95% for bowel cancer patients, but survival falls to approximately 13% once the disease has spread - meaning a delay driven by loss of private cover is not a minor inconvenience but a potentially fatal one.
Of the 33 submissions received, only three explicitly support the government's changes. Deafness Forum Australia and the Tasmanian Association of State Superannuants raised affordability concerns for older members on moderate incomes, while South Australia joined the New South Wales, Queensland and Tasmanian governments in formally opposing the bill on the grounds that it risks worsening elective surgery waiting lists.
Six health economists from the Melbourne Institute of Applied Economic and Social Research were among the minority backing the change, arguing it corrects a poorly targeted subsidy and forecasting between roughly 14,800 and 42,500 policyholders would drop cover - a range broadly consistent with the government's own projection of 44,000 exits.
The inquiry's findings will feed directly into a tight vote. With the Coalition opposing the bill, Labor needs the Greens and at least four crossbench senators to pass it. Independent Senator Jacqui Lambie said in late May she would not support the changes, citing Tasmanian pensioners already cutting back on necessities to keep their private cover. One Nation indicated by early July it would also oppose the bill. As of early July, independent senators David Pocock and Lidia Thorpe remained undecided - Pocock said he had consulted older Australians, medical groups and the AMA; Thorpe said she wanted to see the inquiry's evidence before deciding.
The Senate Community Affairs Legislation Committee is due to report by October 7, 2026.
That deadline creates a specific operational problem. Insurers are expected to submit their 2027 premium applications to the government by mid-November 2026 - which means pricing for the proposed April 1, 2027 commencement will need to be prepared before the October 7 committee report, and potentially before the Senate has voted at all.
Insurers pricing for uncertainty on a change of this scale - affecting approximately 3.05 million policyholders aged 65 and over, including about 2.13 million earning $55,000 or less annually - face the uncomfortable position of building two scenarios into their premium modelling simultaneously. The government approved an average premium increase of 4.41% from April 1, 2026, the highest average increase since 2017. Adding uncertainty about the rebate structure on top of that baseline creates meaningful pricing complexity.
For brokers advising clients aged 65 and over on existing private health cover, the conversation this prompts is specific. Whether or not the bill passes, the 2027 premium round will bring a material increase for older members under almost any scenario. The question for clients is whether they hold their existing cover and absorb the cost, whether they move to a lower-tier product that preserves some private access at a lower price point, or whether they consider dropping cover entirely and relying on the public system for elective procedures. Brokers who initiate that conversation before the October report will have more options available to their clients than those who wait for the Senate vote to clarify the outcome.
